Position in GMAB
as of Mar 31, 2026
· filed May 7, 2026
Position Value
$1,514,231
-$198,957 QoQ
Shares Held
56,438
+1.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 98.44076685920834.ToString("F0")%
Shared 1.559233140791665.ToString("F0")%
None 0.ToString("F0")%
Common Shares in GMAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DIMENSIONAL FUND ADVISORS LP holds $5,003,907,830 across 224 Biotechnology names. GMAB ranks #131 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
989,342 | $441,780,774 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
513,060 | $396,410,676 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,895,215 | $358,290,394 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
3,802,930 | $214,827,514 | |
| 5 | ROIV |
Roivant Sciences Ltd.
|
7,475,866 | $207,081,486 | |
| 6 | INCY |
Incyte Corp
|
1,975,544 | $185,938,199 | |
| 7 | EXEL |
Exelixis, Inc.
|
4,299,597 | $184,409,714 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
2,079,827 | $134,419,216 |
All Filings in GMAB
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,514,231 | 56,438 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $1,713,188 | 55,623 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,727,641 | 56,330 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $1,097,149 | 53,105 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $995,075 | 50,821 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $951,985 | 45,615 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,719,009 | 70,509 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $2,137,356 | 85,052 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $2,805,916 | 93,812 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $2,978,823 | 93,556 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $3,343,031 | 94,784 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,563,855 | 93,761 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,799,677 | 74,144 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,560,387 | 60,415 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $1,762,716 | 54,862 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $1,725,154 | 53,098 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $660,031 | 18,243 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $611,241 | 15,451 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $259,665 | 5,942 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $215,664 | 5,282 | Shares | Sole | 2021-08-12 | |
| 2020-12-31 | $214,766 | 5,282 | Shares | Sole | 2021-03-08 | |
| No filing history on record for this holder in this stock. | ||||||